Viridian Therapeutics
VRDN
VRDN
128 hedge funds and large institutions have $1.12B invested in Viridian Therapeutics in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 69 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 135 → 128 (-7)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
37% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $18.8M
Holders
128
Holding in Top 10
9
Calls
$11.9M
Puts
$18.8M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$25M | |
| 3 | +$17.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$14.4M | |
| 3 | -$8.65M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.68M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$6.23M |